Pancreatic Cancer Research

ResearcherAffiliated Hangzhou First People's Hospital, Westlake University, School of MedicineNo recent work listed

Shenglin Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-2355-7938; OpenAlex author ID A5108050852. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers

Papers 3

  1. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition. Last author DOI 10.3892/mmr.2018.8763↗
  2. Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling. Last author DOI 10.3892/ol.2018.9455↗
  3. The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51. Co-author DOI 10.1016/j.biopha.2017.02.067↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianfeng Yang · 2 shared papers, 2018 · strength 0.20
  2. Hangbin Jin · 1 shared paper, 2018 · strength 0.11
  3. Hangbin Jin · 1 shared paper, 2018 · strength 0.10
  4. Shirong Zhang · 1 shared paper, 2018 · strength 0.10
  5. Xufeng Chen · 1 shared paper, 2017 · strength 0.07
  6. Zhibing Wu · 1 shared paper, 2017 · strength 0.07
  7. Saisai Jing · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.